Literature DB >> 10488143

Purification and characterization of a membrane-bound nonlysosomal ceramidase from rat brain.

S El Bawab1, A Bielawska, Y A Hannun.   

Abstract

We have purified a membrane bound ceramidase 22,300-fold to apparent homogeneity. The purification scheme included Triton X-100 extraction of membranes followed by Q-Sepharose, blue Sepharose, phenyl-Sepharose, and MonoS column chromatography. The purified enzyme showed an apparent molecular mass of 90 kDa as estimated by SDS-polyacrylamide gel electrophoresis under reducing conditions and 95 kDa by chromatography on Superose 12. Using C(16)-ceramide as substrate, the enzyme showed a broad pH optimum in the neutral to alkaline range. A mixed micelle assay was developed, and using Triton X-100/ceramide mixed micelles, the enzyme exhibited classical Michaelis-Menten kinetics, with a K(m) of 1.29 mol % and a V(max) of 4.4 micromol/min/mg. When dihydroceramide was used as substrate, these values were 3.84 mol % and 1.2 micromol/min/mg, respectively, indicating that the enzyme hydrolyzes ceramides preferentially. The activity of the purified ceramidase did not require cations, and it was inhibited by reducing agents. Phosphatidylcholine and sphingomyelin were without effect on the enzyme activity, whereas phosphatidic acid and phosphatidylserine stimulated the activity 3-fold. Sphingosine acted as a competitive inhibitor with an IC(50) of 5-10 microM. These results indicate that the purified enzyme is a novel ceramidase.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10488143     DOI: 10.1074/jbc.274.39.27948

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

Review 1.  Treating glucosphingolipid disorders by chemotherapy: use of approved drugs and over-the-counter remedies.

Authors:  N S Radin
Journal:  J Inherit Metab Dis       Date:  2000-12       Impact factor: 4.982

2.  Essential roles of neutral ceramidase and sphingosine in mitochondrial dysfunction due to traumatic brain injury.

Authors:  Sergei A Novgorodov; Christopher L Riley; Jin Yu; Keith T Borg; Yusuf A Hannun; Richard L Proia; Mark S Kindy; Tatyana I Gudz
Journal:  J Biol Chem       Date:  2014-03-21       Impact factor: 5.157

3.  New fluorogenic probes for neutral and alkaline ceramidases.

Authors:  Mireia Casasampere; Núria Bielsa; Daniel Riba; Laura Bassas; Ruijuan Xu; Cungui Mao; Gemma Fabriàs; José-Luis Abad; Antonio Delgado; Josefina Casas
Journal:  J Lipid Res       Date:  2019-03-29       Impact factor: 5.922

Review 4.  Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases.

Authors:  Daniel Canals; David M Perry; Russell W Jenkins; Yusuf A Hannun
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

5.  Conformational characterization of ceramides by nuclear magnetic resonance spectroscopy.

Authors:  Li Li; Xiaoping Tang; K Grant Taylor; Donald B DuPré; M Cecilia Yappert
Journal:  Biophys J       Date:  2002-04       Impact factor: 4.033

6.  Degradation of glycosphingolipids in oyster: ceramide glycanase and ceramidase in the hepatopancreas of oyster, Crassostrea virginica.

Authors:  Nadejda V Pavlova; Su-Chen Li; Yu-Teh Li
Journal:  Glycoconj J       Date:  2017-10-16       Impact factor: 2.916

Review 7.  Plant sphingolipids: decoding the enigma of the Sphinx.

Authors:  Mickael O Pata; Yusuf A Hannun; Carl K-Y Ng
Journal:  New Phytol       Date:  2009-12-16       Impact factor: 10.151

8.  Role of alkaline ceramidases in the generation of sphingosine and its phosphate in erythrocytes.

Authors:  Ruijuan Xu; Wei Sun; Junfei Jin; Lina M Obeid; Cungui Mao
Journal:  FASEB J       Date:  2010-03-05       Impact factor: 5.191

9.  Potent inhibition of Acid ceramidase by novel B-13 analogues.

Authors:  Denny Proksch; Jan Jasper Klein; Christoph Arenz
Journal:  J Lipids       Date:  2010-12-09

10.  Role of neutral ceramidase in colon cancer.

Authors:  Mónica García-Barros; Nicolas Coant; Toshihiko Kawamori; Masayuki Wada; Ashley J Snider; Jean-Philip Truman; Bill X Wu; Hideki Furuya; Christopher J Clarke; Agnieszka B Bialkowska; Amr Ghaleb; Vincent W Yang; Lina M Obeid; Yusuf A Hannun
Journal:  FASEB J       Date:  2016-09-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.